%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% Glossary terms
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%



\newglossaryentry{pleiotropy}{%
  name=pleiotropy,
  description={When a gene has multiple biological functions},
  plural=pleiotropic
}

\newglossaryentry{E-cadherin}{%
  name=E-cadherin,
  description={Epithelial cadherin (calcium-dependent adhesion), a cell-adhesion protein encoded by \textit{CDH1}}
}

%\newglossaryentry{Pan cancer}{
%  name=Pan cancer,
%  description={Study or analysis of cancers across tissue of origin}
%}

\newglossaryentry{pan cancer}{%
  name=pan cancer,
  description={A focus on the molecular and genetic features across cancers in different tissues},
  plural=Pan Cancer
}

\newglossaryentry{RNA-Seq}{%
  name=RNA-Seq,
  description={The generation of transcriptome data from sequencing RNA}
}

\newglossaryentry{CAGE-Seq}{%
  name=CAGE-Seq,
  description={Transcriptome data from cap analysis of gene expression}
}

\newglossaryentry{gls-ChIP-Seq}{%
  name=ChIP-Seq,
  description={Epigenome data from chromatin immunopreciptation sequencing}
}

\newglossaryentry{bisulfite-Seq}{%
  name=bisulfite-Seq,
  description={Epigenomic data from sequencing bisulfite treated DNA}
}

\newglossaryentry{Sanger}{%
  name=Sanger sequencing,
  description={A dideoxy chain termination method for DNA sequencing (named after Fred Sanger)}
}

\newglossaryentry{genomic}{%
  name=genomic,
  description={The use of data from all genes in the genome},
  plural=genomics
}

\newglossaryentry{genome}{%
  name=genome,
  description={All of the DNA sequence in the genome},
  plural=genomes
}


\newglossaryentry{transcriptome}{%
  name=transcriptome,
  description={All of the genes expressed in the genome},
  plural=transcriptomes
}

\newglossaryentry{metagenome}{%
  name=metagenome,
  description={All of the genes and genomes in a community},
  plural=metagenomics %%switch
}

\newglossaryentry{epigenome}{%
  name=epigenome,
  description={An analysis of epigenetic modifications of all genes in the genome},
  plural=epigenomics
}

\newglossaryentry{proteome}{%
  name=proteome,
  description={All the proteins expressed from the genome},
  plural=proteomics
}

\newglossaryentry{metabolome}{%
  name=metabolome,
  description={All the metabolites and enzymes in the cell},
  plural=metabolomics
}

%\newglossaryentry{methylome}{
%  name=Methylome,
%  description={An analysis of DNA methylation throughout the genome},
%  plural=methylomics
%}

\newglossaryentry{exome}{%
  name=exome,
  description={A sequencing approach designed to generate data enriched for coding genes within the genome}
}

\newglossaryentry{bioinformatics}{%
  name=bioinformatics,
  description={Statistical or computational approaches to biological data or research tools},
  plural=bioinformatic %%switch
}

\newglossaryentry{computational biology}{%
  name=computational biology,
  description={Applying computational or mathematical modelling to understanding biological systems and relationships},
  plural=computational biology %%switch
}


\newglossaryentry{microRNA-gls}{
  name=microRNA,
  description={Short RNA molecules generally regarded to regulate gene expression by binding to mRNA},
  plural=microRNAs
}

\newglossaryentry{synthetic lethal}{%
  name=synthetic lethal,
  description={Genetic interactions where inactivation of multiple genes is inviable (or deleterious) which are viable if inactivated separately},
  plural=synthetic lethality
}

\newglossaryentry{synthetic sick}{%
  name=synthetic sick,
  description={Genetic interactions where inactivation of multiple genes is deleterious which are viable if inactivated separately},
  plural=synthetic lethality
}

\newglossaryentry{microarray}{%
  name=microarray,
  description={A high-throughput technique to measure presence or abundance of nucleic acid sequences from binding to probes},
  plural=microarrays
}

\newglossaryentry{copy number}{%
  name=copy number,
  description={The number of copies of DNA, typically two copies for diploid organisms but subject to variation},
  plural=copy number
}

\newglossaryentry{gene expression}{%
  name=gene expression,
  description={A measure of the relative expression of each gene from the mRNA extracted from (pooled) cells},
  plural=gene expression
}


\newglossaryentry{methylation}{%
  name=methylation,
  description={A measure of the epigenetic regulation of DNA at CpG sites},
  plural=methylation
}

\newglossaryentry{omics}{%
  name='omics,
  description={A combination of approaches to generating biological data with high-throughput procedures such as genomics, proteomics or metabolomics},
  plural=omics
}

%\newglossaryentry{omics}{
%  name=omics,
%  description={A rationale for applying molecular studies across all of the genes in the genome or biomolecules in the cell},
%  plural=omic %%switch
%}

\newglossaryentry{cancer}{%
  name=cancer,
  description={A class of diseases, formally ``malignant neoplasm'', of abnormal cellular growth and spread to other organs},
  plural=cancers
}

\newglossaryentry{tumour}{%
  name=tumour,
  description={An abnormal lump of tissue or growth of cells, may be cancerous},
  plural=tumours
}

\newglossaryentry{metastasis}{%
  name=metastasis,
  description={A secondary growth of a tumour or spread of cancer to other organs},
  plural=metastasize 
}

\newglossaryentry{cancer gene}{%
  name=cancer gene,
  description={A gene which is involved in the malignancy of some cancers, encompassing \glspl{oncogene} and \glspl{tumour suppressor}, which have molecular aberrations in cancer or variants which predispose individuals to cancer},
  plural=cancer genes
}

\newglossaryentry{oncogene}{%
  name=oncogene,
  description={A gene that potentially causes cancer, typically by over-expression or mutant gene variants},
  plural=oncogenes
}

\newglossaryentry{proto-oncogene}{%
  name=proto-oncogene,
  description={The non-mutant variant or precursor to a \gls{mutant} \gls{oncogene}},
  plural=proto-oncogenes
}

\newglossaryentry{tumour suppressor}{%
  name=tumour suppressor,
  description={A gene potentially causes cancer, typically by disruption of functions which protect the cell from cancer},
  plural=tumour suppressors
}

\newglossaryentry{mutation}{%
  name=mutation,
  description={A change in DNA sequence that disrupts gene function},
  plural=mutations
}

\newglossaryentry{driver mutation}{%
  name=driver mutation,
  description={A \gls{mutation} which promotes cancer growth},
  plural=driver mutations
}

\newglossaryentry{passenger mutation}{%
  name=passenger mutation,
  description={A \gls{mutation} that occurs in cancers but does not affect the growth of cancers},
  plural=passenger mutations
}

\newglossaryentry{genomic medicine}{%
  name=genomic medicine,
  description={The use of genomic information to tailor medicine treatment to the genetics of an individual},
  plural=genomic medicine
}

\newglossaryentry{precision medicine}{%
  name=precision medicine,
  description={The application of prevention and treatment measures to target diseases by molecular and genetic features},
  plural=precision cancer medicine
}

\newglossaryentry{recurrent mutation}{%
  name=recurrent mutation,
  description={The repeated occurrence of mutations in a particular gene across cancers},
  plural=recurrent mutations
}

\newglossaryentry{metagene}{%
  name=metagene,
  description={A consistent signal of expression for a collection of genes such as a biological pathway, derived from singular value decomposition},
  plural=metagenes
}

\newglossaryentry{polypharmacology}{%
  name=polypharmacology,
  description={The design of drugs to target multiple molecular targets or biological pathways},
  plural=polypharmacology
}

\newglossaryentry{targeted therapy}{%
  name=targeted therapy,
  description={Cancer treatment that specifically acts against a molecular target, in contrast to standard chemotherapy},
  plural=targeted therapeutic
}

\newglossaryentry{network biology}{%
  name=network biology,
  description={The application mathematical and computational approaches to networks in understanding biological relationships},
  plural=network biology
}

\newglossaryentry{network medicine}{%
  name=network medicine,
  description={The use  of \gls{network biology} to understand, prevent, or treat diseases},
  plural=network medicine
}

\newglossaryentry{intrinsic subtype}{%
  name=intrinsic subtype,
  description={Distinguishing cancer by molecular and genetic features},
  plural=intrinsic subtypes
}

\newglossaryentry{chemotherapy}{%
  name=chemotherapy,
  description={The use of cytotoxic drugs to treat cancers, in combinations, generally applied to advanced stage cancers},
  plural=chemotherapy
}

\newglossaryentry{chemoprevention}{%
  name=chemoprevention,
  description={The use of drugs to prevent early-stage cancers, generally applied to high-risk mutation carriers},
  plural=chemopreventative
}


\newglossaryentry{diagnosis}{%
  name=diagnosis,
  description={The identification of disease by clinical, cellular, and molecular characteristics},
  plural=diagnose
}


\newglossaryentry{prognosis}{%
  name=prognosis,
  description={The estimation of disease progression and patient outcome},
  plural=prognosis
}


\newglossaryentry{treatment}{%
  name=treatment,
  description={Medical procedures for a disease to improve patient outcomes},
  plural=treatments
}


\newglossaryentry{wild-type}{%
  name=wild-type,
  description={A natural phenotype of a trait or the normally functional \gls{allele} which encodes it},
  plural=wild-type
}


\newglossaryentry{mutant}{%
  name=mutant,
  description={A variant or dysfunctional phenotype arising from a \gls{mutation} in a gene},
  plural=mutant
}


\newglossaryentry{somatic}{%
  name=somatic mutation,
  description={A \gls{mutation} that occurs in somatic cells, during a patient's lifespan},
  plural=somatic
}

\newglossaryentry{germline}{%
  name=germline mutation,
  description={A \gls{mutation} that occurred in germline cells and is passed between generation},
  plural=germline
}

\newglossaryentry{allele}{%
  name=allele,
  description={A gene variant with a specific sequence and phenotype},
  plural=alleles
}

\newglossaryentry{familial}{%
  name=familial,
  description={A trait recurrently occurring in families, not necessarily with a genetic cause},
  plural=familial
}


\newglossaryentry{hereditary}{%
  name=hereditary,
  description={A trait or disease which has a genetic cause and is inherited from family members},
  plural=hereditary
}


\newglossaryentry{sporadic}{%
  name=sporadic cancer,
  description={Cancers which do occur in patients with a family history or carry a high-risk genetic variant},
  plural=sporadic
}


\newglossaryentry{hub}{%
  name=hub,
  description={A central or highly connected component of a network},
  plural=hubs
}


\newglossaryentry{vertex}{%
  name=vertex or node,
  description={An element of a graph structure or network},
  plural=vertices
}


\newglossaryentry{edge}{%
  name=edge or link,
  description={A relationship connecting a pair of elements of a graph structure or network, may be weighted or directional},
  plural=edges
}


\newglossaryentry{graph}{%
  name=graph or network,
  description={A mathematical structure modelling or depicting the relationships between elements},
  plural=graphs
}


\newglossaryentry{oncogene addiction}{%
  name=oncogene addiction,
  description={The dependence of a cancer cell on a specific oncogenic pathway},
  plural=oncogene addiction
}


\newglossaryentry{non-oncogene addiction}{%
  name=non-oncogene addiction,
  description={The dependence of a cancer cell on functioning non-mutant genes},
  plural=non-oncogene addiction
}


\newglossaryentry{hallmark}{%
  name=hallmark of cancer,
  description={An underlying characteristic of cancer as part of a rational approach devised by \citep{Hanahan2000}},
  plural=hallmarks
}


\newglossaryentry{induced essentiality}{
  name=induced essentiality,
  description={A gene becoming \gls{essential} to viability under certain conditions, including inactivation of a synthetic lethal partner},
  plural=induced essentiality
}


\newglossaryentry{essential}{%
  name=essential,
  description={A gene which is required to be functional or expressed for a cell or organism to be viable, grow or develop},
  plural=essentiality
}

\newglossaryentry{conditional essentiality}{%
  name=conditional essentiality,
  description={A gene becoming essential to viability under certain environmental conditions, including presence of compounds which inactivate other genes},
  plural=conditional essentiality
}


\newglossaryentry{functional redundancy}{%
  name=functional redundancy, 
  description={Genes which perform a common function, also known as genetic redundancy},
  plural=functional redundancy
}


\newglossaryentry{genetic robustness}{%
  name=genetic robustness,
  description={A system of biological pathways which (has evolved to) continue to function as a whole under various conditions, including the inactivation of various individual genes},
  plural=genetically robust %adj
}


\newglossaryentry{synthetic dosage lethal}{%
  name=synthetic dosage lethal,
  description={A \acrfull{SGI} analogous to \glspl{synthetic lethal} where %genes are disrupted by a change in dosage, typically
  where one gene is inactivated and the other over-expressed },
  plural=synthetic dosage lethality
}


\newglossaryentry{synthetic lethal screen}{%
  name=synthetic lethal screen,
  description={A \gls{high-throughput screen} performed on isogenic cell lines to detect genes for which inhibition specifically deleterious to the null \gls{mutant} genotype},
  plural=synthetic lethal screening
}


\newglossaryentry{high-throughput screen}{%
  name=high-throughput screen,
  description={An experimental procedure to perform a large scale series of chemical, genetic, or pharmacological tests},
  plural=high-throughput screens
}


\newglossaryentry{compound screen}{%
  name=compound screen,
  description={A \gls{high-throughput screen} performed using a library of chemical compounds},
  plural=compound screening
}

\newglossaryentry{RNAi screen}{%
  name=RNAi screen,
  description={A \gls{high-throughput screen} performed using a \acrfull{RNAi}},
  plural=RNAi screening
}


\newglossaryentry{MCF10A}{%
  name=MCF10A cell line,
  description={A non-tumorigenic epithelial cell line derived from breast tissue},
  plural=MCF10A cells
}


\newglossaryentry{in silico}{%
  name=\textit{in silico},
  description={An investigation conducted using computations, typically simulations or analyses},
  plural=in silico
}


\newglossaryentry{in vivo}{%
  name=\textit{in vivo},
  description={An investigation conducted using in the context of a biological cell or organism, including pre-clincal models and clinical trials},
  plural=in vivo
}


\newglossaryentry{in vitro}{%
  name=\textit{in vitro},
  description={An investigation conducted using a controlled experimental system to examine biomolecules},
  plural=in vitro
}


\newglossaryentry{de novo}{%
  name=\textit{de novo},
  description={A bioinformatics sequence assembly conducted entirely from raw genomics data without a reference sequence},
  plural=de novo
}


\newglossaryentry{scale-free}{%
  name=scale-free,
  description={A property of a network which has a power law \gls{vertex degree} distribution, that is several highly connected \gls{hub} genes and many with very few connections},
  plural=scale-free
}


\newglossaryentry{small world}{%
  name=small world,
  description={A property of a network which is highly connected and has a low characteristic path length, derived from the mean \gls{shortest path} length across all pairs of nodes},
  plural=small worlds
}


\newglossaryentry{shortest path}{%
  name=shortest path,
  description={A path with the fewest possible \glspl{edge} which connects two particular \glspl{vertex}},
  plural=shortest paths
}


\newglossaryentry{centrality}{%
  name=centrality,
  description={A network metric which identifies important \glspl{vertex}},
  plural=centrality
}


\newglossaryentry{information centrality}{%
  name=information centrality,
  description={A network \gls{centrality} metric which uses the impact of removing a \gls{vertex} on connections in the network},
  plural=information centrality
}


\newglossaryentry{PageRank centrality}{%
  name=PageRank centrality,
  description={A network \gls{centrality} metric which uses eigenvectors with a scaling factor \citep{Brin1998}},
  plural=pagerank centrality
}


\newglossaryentry{vertex degree}{%
  name=vertex degree,
  description={A network metric of connectivity of \glspl{vertex} which uses the number of edges connected to each \gls{vertex}},
  plural=vertex degree
}


\newglossaryentry{synergy}{%
  name=synergy,
  description={When multiple drugs have more effect than expected from the effect of each separately},
  plural=synergistic
}


\newglossaryentry{synthetic suppression}{%
  name=synthetic suppression,
  description={A \acrlong{SGI} when the combined \glspl{mutation} (partially) suppresses the \gls{mutant} phenotype of one of the \glspl{mutation}},
  plural=synthetic suppression
}


\newglossaryentry{synthetic rescue}{%
  name=synthetic rescue,
  description={A \acrlong{SGI} when the combined \glspl{mutation} restores the \gls{wild-type} the phenotype of one of the \glspl{mutation}},
  plural=synthetic rescue
}


\newglossaryentry{epistasis_bio}{%
  name=epistasis (biological),
  description={The effects of a gene modifying or masking the phenotype of another gene},
  plural=epistasis
}


\newglossaryentry{epistasis_stat}{%
  name=epistasis (statistical),
  description={A divergence of the observed double \gls{mutant} phenotype from that expected based on the respective phenotypes of single \glspl{mutant}  \citep{Fisher1919}},
  plural=epistasis
}


\newglossaryentry{pathway}{%
  name=pathway,
  description={A series of biomolecules that produces a particular product or biological function},
  plural=pathways
}


\newglossaryentry{molecular profile}{%
  name=molecular profile,
  description={A combination of genetic and biochemical measures which identifies characteristic traits of a tumour},
  plural=molecular profiles %ing?
}


\newglossaryentry{molecular subtype}{%
  name=molecular subtype,
  description={A classification of cancers based on an identification using molecular properties},
  plural=molecular subtypes %ing?
}



%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% Acronym terms
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\newacronym[description={Nonsense-Mediated Decay}]{NMD}{NMD}{nonsense-mediated decay}%
\newacronym[description={G-protein Signalling}]{RGS}{RGS}{G-protein signalling}%
\newacronym[description={Chemokine Receptor}, plural=CXCRs,firstplural=Chemokine receptors]{CXCR}{CXCR}{chemokine receptors}%
\newacronym[description={Ras Homolog Family}]{RHO}{RHO}{Ras homolog family}%
\newacronym[description={Untranslated Region (of mRNA)}]{UTR}{UTR}{untranslated region}%

\newacronym[description={Transforming Growth Factor $\alpha$}]{TGFA}{TGF$\alpha$}{transforming growth factor $\alpha$}%
\newacronym[description={Transforming Growth Factor $\beta$}]{TGFB}{TGF$\beta$}{transforming growth factor $\beta$}%

\newacronym[description={Bone Morphogenic Protein}, plural=BMPs]{BMP}{BMP}{bone morphogenic protein}%

\newacronym[description={Gene Ontology}]{GO}{GO}{Gene Ontology}%

\newacronym[description={Janus Kinase}]{JAK}{JAK}{Janus kinase}%

\newacronym[description={Histone Deacetylase}]{HDAC}{HDAC}{histone deacetylase}%

\newacronym[description={G Protein Coupled Receptor}, plural=GPCRs,firstplural=G protein coupled receptors]{GPCR}{GPCR}{G protein coupled receptor}%

\newacronym[description={AMP-activated Protein Kinase}]{AMPK}{AMPK}{AMP-activated protein kinase}%

\newacronym[description={Phosphodiesterase}]{PDE}{PDE}{phosphodiesterase}%
 
\newacronym[description={Phosphoinositide 3-kinase}]{PI3K}{PI3K}{phosphoinositide 3-kinase}%

\newacronym[description={Hereditary Leiomyomatosis and Renal Cell Carcinoma}]{HLRCC}{HLRCC}{Hereditary leiomyomatosis and renal cell carcinoma}%

\newacronym[description={Hereditary Diffuse Gastric Cancer}]{HDGC}{HDGC}{hereditary diffuse gastric cancer}%

\newacronym[description={Epithelial-Mesenchymal Transition}]{EMT}{EMT}{epithelial-mesenchymal transition}%

\newacronym[description={Wingless-Related Integration Site}]{WNT}{WNT}{Wingless-related integration site}%

\newacronym[description={Next-Generation Sequencing}]{NGS}{NGS}{``Next-Generation Sequencing''}%

\newacronym[description={Deoxyribonucleic Acid}]{DNA}{DNA}{deoxyribonucleic acid}%

\newacronym[description={Ribonucleic Acid}]{RNA}{RNA}{ribonucleic acid}%

\newacronym[description={RNA Interference}]{RNAi}{RNAi}{RNA interference}%

\newacronym[description={Messenger RNA}]{mRNA}{mRNA}{messenger RNA}%

\newacronym[description={Micro RNA}, plural=microRNAs,firstplural=microRNAs]{microRNA}{microRNA}{micro RNA}%

\newacronym[description={Short Interfering RNA}, plural=siRNAs,firstplural=siRNAs]{siRNA}{siRNA}{short interfering RNA}%

\newacronym[description={Short Hairpin RNA}, plural=shRNAs,firstplural=shRNAs]{shRNA}{shRNA}{short hairpin RNA}%

\newacronym[description={Ribonucleic acid}]{rRNA}{rRNA}{RNA}%

\newacronym[description={Transfer RNA}]{tRNA}{tRNA}{transfer RNA}%

\newacronym[description={Complementary DNA (from mRNA)}]{cDNA}{cDNA}{complementary DNA}%

\newacronym[description={Polymerase Chain Reaction}]{PCR}{PCR}{polymerase chain reaction}%

\newacronym[description={Quantitative (real-time) Polymerase Chain Reaction}]{qPCR}{qPCR}{quantitative PCR}%

\newacronym[description={Restriction Fragment Length Polymorphism}]{RFLP}{RFLP}{restriction fragment length polymorphism}%

\newacronym[description={Single Nucleotide Polymorphism}, plural=SNPs,firstplural=SNPs]{SNP}{SNP}{single nucleotide polymorphism}%

\newacronym[description={Long Non-Coding RNA}]{lncRNA}{lncRNA}{long non-coding RNA}%

\newacronym[description={Reduced Representation Bisulfite Sequencing}]{RRBS}{RRBS}{reduced representation bisulfite sequencing}%

\newacronym[description={Chromatin Immunopreciptation Sequencing}]{ChIP-Seq}{ChIP-Seq}{chromatin immunopreciptation sequencing}%
\newacronym[description={Chromatin Immunopreciptation}]{ChIP}{ChIP}{chromatin immunopreciptation}%
%see={[Glossary:]gls-ChIP-Seq}}

\newacronym[description={Insertion or Deletion (in \acrshort{DNA} sequence)}, plural=InDels,firstplural=insertions or deletions]{InDel}{InDel}{InDel}%

\newacronym[description={Cancer Genome Project}]{CGP}{CGP}{Cancer Genome Project}%
\newacronym[description={Cancer Cell Line Encyclopaedia}]{CCLE}{CCLE}{Cancer Cell Line Encyclopaedia}%
\newacronym[description={National Institutes of Health (in the USA)}]{NIH}{NIH}{National Institutes of Health}%
\newacronym[description={The Cancer Genome Atlas (genomics project)}]{TCGA}{TCGA}{The Cancer Genome Atlas}%
\newacronym[description={International Cancer Genome Consortium}]{ICGC}{ICGC}{International Cancer Genome Consortium}%
\newacronym[description={National Cancer Institute (in the USA)}]{NCI}{NCI}{National Cancer Institute}%
\newacronym[description={National Human Genome Research Institute (in the USA)}]{NHGRI}{NHGRI}{National Human Genome Research Institute}%
\newacronym[description={National Center for Biotechnology Information (in the USA)}]{NCBI}{NCBI}{National Center for Biotechnology Information}%
\newacronym[description={European Molecular Biology Laboratory}]{EMBL}{EMBL}{European Molecular Biology Laboratory}%
\newacronym[description={The European Nucleotide Archive}]{ENA}{ENA}{The European Nucleotide Archive}%
\newacronym[description={DNA Data Bank of Japan}]{DDBJ}{DDBJ}{DNA Data Bank of Japan}%
\newacronym[description={National Institute of Genetics (in Japan)}]{NIG}{NIG}{National Institute of Genetics}%
\newacronym[description={Gene Expression Omnibus}]{GEO}{GEO}{Gene Expression Omnibus}%
\newacronym[description={Encyclopaedia of DNA Elements}]{ENCODE}{ENCODE}{Encyclopaedia of DNA Elements}%
\newacronym[description={Functional Annotation Of Mammalian genome}]{FANTOM}{FANTOM}{Functional Annotation Of Mammalian genome}%

%%To add:
\newacronym[description={Phosphatidylinositol-(4,5)-bisphosphate}]{PIP2}{PIP$_2$}{phosphatidylinositol-(4,5)-bisphosphate}%
\newacronym[description={Phosphatidylinositol-(3,4,5)-trisphosphate}]{PIP3}{PIP$_3$}{phosphatidylinositol-(3,4,5)-trisphosphate}%
\newacronym[description={Adenosine Triphosphate}]{ATP}{ATP}{adenosine triphosphate}%
\newacronym[description={Adenosine Diphosphate}]{ADP}{ADP}{adenosine diphosphate}%
\newacronym[description={Adenosine Monophosphate}]{AMP}{AMP}{adenosine monophosphate}%
\newacronym[description={Cylic AMP}]{cAMP}{cAMP}{cylic AMP}%
 
\newacronym[description={5$^\prime$--C--phosphate--G--3$^\prime$}]{CpG}{CpG}{CpG dinucleotide}%
\newacronym[description={Catalogue Of Somatic Mutations In Cancer}]{COSMIC}{COSMIC}{Catalogue Of Somatic Mutations In Cancer}%
\newacronym[description={1000 genomes project}]{1KGP}{1KGP}{1000 genomes project}%
\newacronym[description={Molecular Taxonomy of Breast Cancer International Consortium}]{METABRIC}{METABRIC}{Molecular Taxonomy of Breast Cancer International Consortium}%
\newacronym[description={Copy Number Variation}]{CNV}{CNV}{\gls{copy Number} variation}%

\newacronym[description={Poly-ADP-Ribose Polymerase}]{PARP}{PARP}{Poly-ADP-ribose polymerase}%

%%

% \gls{PAM50}: Prediction Analysis of Microarray 50
% \gls{UCSC} University of California, Santa Cruz (accessed https://genome-cancer.ucsc.edu/proj/site/hgHeatmap/, Mar 29  2012)

\newacronym[description={Prediction Analysis of Microarray 50}]{PAM50}{PAM50}{Prediction Analysis of Microarray 50}%

\newacronym[description={University of California, Santa Cruz}]{UCSC}{UCSC}{University of California, Santa Cruz}
%
\newacronym[description={Reverse Phase Protein Arrays}]{RPPA}{RPPA}{reverse phase protein arrays}%

\newacronym[description={Synthetic Lethal Interaction Prediction Tool}]{SLIPT}{SLIPT}{Synthetic Lethal Interaction Prediction Tool}%

\newacronym[description={Data Mining Synthetic Lethal Identification Pipeline}]{DAISY}{DAISY}{``DAta mIning SYnthetic lethal identification pipeline''}%

\newacronym[description={Bimodal Subsetting Expression}]{BiSEp}{BiSEp}{BImodal Subsetting ExPression}%

\newacronym[description={Estrogen Receptor}]{ER}{ER}{Estrogen receptor}%

\newacronym[description={Progesterone Receptor}]{PR}{PR}{Progesterone receptor}%

\newacronym[description={False Discovery Rate}]{FDR}{FDR}{False discovery rate}%

\newacronym[description={Synthetic Lethality (expression)}]{exprSL}{exprSL}{synthetic lethality (expression)}

\newacronym[description={synthetic Lethality (mutation)}]{mtSL}{mtSL}{synthetic lethality (mutation)}

\newacronym[description={Synthetic Lethal Interaction Prediction Tool (against mutation)}]{mtSLIPT}{mtSLIPT}{mutation SLIPT}%

\newacronym[description={Robust Multiarray Averaging (normalisation}]{RMA}{RMA}{Robust Multiarray Averaging}%

\newacronym[description={Trimmed Mean of M values (normalisation}]{TMM}{TMM}{trimmed mean of M values}%

\newacronym[description={Counts Per Million mapped reads}]{CPM}{CPM}{Counts per Million mapped reads}%

\newacronym[description={Reads Per Kilobase per Million mapped reads}]{RPKM}{RPKM}{Reads Per Kilobase per Million mapped reads}%

\newacronym[description={RNA-Seq by Expectation Maximization (normalisation)}]{RSEM}{RSEM}{RNA-Seq by Expectation Maximization}%

\newacronym[description={Area Under the Receiver Operating Characteristic (curve)}]{AUROC}{AUROC}{area under \acrlong{ROC}}%

\newacronym[description={Reciever Operating Characteristic (curve)}]{ROC}{ROC}{receiver operating characteristic}%

\newacronym[description={Analysis of Variance}]{ANOVA}{ANOVA}{analysis of variance}%

\newacronym[description={Comprehensive R Archive Network}]{CRAN}{CRAN}{comprehensive R archive network}%

\newacronym[description={Biological Pathway Exchange}]{BioPAX}{BioPAX}{Biological PAthway eXchange}%

\newacronym[description={Simple Linux Utility for Resource Management}]{Slurm}{Slurm}{Simple Linux Utility for Resource Management}%

\newacronym[description={New Zealand eScience Infrastructure}]{NeSI}{NeSI}{the New Zealand eScience Infrastructure}%

\newacronym[description={High Performance Computing}]{HPC}{HPC}{High Performance Computing}%

\newacronym[description={Protein-Protein Interaction}, plural=PPIs,firstplural=protein-protein  interactions]{PPI}{PPI}{protein-protein interaction}%

\newacronym[description={Synthetic Genetic Interaction}, plural=SGIs,firstplural=synthetic genetic interactions]{SGI}{SGI}{synthetic genetic interaction}%

\newacronym[description={Synthetic Lethal}]{SL}{SL}{``synthetic lethal''}%

\newacronym[description={Synthetic Sick}]{SSL}{SSL}{``synthetic sick''}%

\newacronym[description={Synthetic Suppression}]{SS}{SS}{``suppression''}%

\newacronym[description={Synthetic Rescue (or viability)}]{SR}{SR}{``rescue''}%

\newacronym[description={Synthetic Gene Array (technique)}, plural=SGAs,firstplural=synthetic gene arrays]{SGA}{SGA}{synthetic gene array}%

\newacronym[description={Microsatellite Instability}]{MSI}{MSI}{microsatellite instability}%

\newacronym[description={Immunohistochemistry}]{IHC}{IHC}{immunohistochemistry}%

\newacronym[description={Bourne Again Shell}]{Bash}{Bash}{Bourne Again SHell}%

\newacronym[description={Central Processing Unit}, plural=CPUs,firstplural=CPUs]{CPU}{CPU}{central processing unit}%

\newacronym[description={Socket Secure}]{SOCKS}{SOCKS}{Socket Secure}%


%%linked entry
\iffalse
\newglossaryentrygls-OWD} {
  name={One-Way Delay},
  description={The time a packet uses through a network from one host to another},
}
\newacronym[see={[Glossary:]gls-OWD}}]{OWD}{OWD}{One-Way Delay\glsaddgls-OWD}}
\fi